Cardiology
The Future of Cardiology Starts Before the First Heart Attack
World Heart Day 2026 is putting prevention back at the centre of cardiology. From once-in-a-lifetime Lp(a) testing and AI-enhanced ECGs to newer cardiometabolic therapies, the field is moving further upstream. But the biggest gains may still depend on detecting and treating familiar risks such as hypertension before symptoms appear.
AI can flag hidden cardiac risk. The dangerous part is what health systems do next
Metabolic syndrome may leave a signature in mitochondrial DNA. The biomarker race should not outrun the evidence
AstraZeneca’s heart drug failure raises a brutal question: how much treatment is too much treatment?
Beans for men, broccoli for women? The real cardiometabolic warning is that risk starts by 22
Why some “resistant” hypertension isn’t resistant at all, and what cardiology might be missing
Treating hypertension in pregnancy is possible. Making it routine care is the policy challenge
Ultra-processed food may leave a metabolic fingerprint in the blood.
New global heart failure definition exposes a policy gap: systems still diagnose too late and treat too narrowly
Moldova Is Taking Vaccines To Roma Communities. Respect Is Part Of Delivery.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
Diseases in Cardiology
Explore disease data and country profiles on the IPM Alliance platform.
Explore diseases